News REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery | BioSpace ROCKVILLE, Md., Aug. 25, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives…Super UserAugust 31, 2020
News Arcellx Announces EvansMDS Grant Awarded for Collaboration with Johns Hopkins and University of Colorado Researchers to Support Development of Arcellx ARC-sparX Platform Candidate ACLX-002 GAITHERSBURG, Md., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Arcellx today announced the award of an EvansMDS Discovery Research Grant to…Super UserAugust 31, 2020
News Crisis innovators: How 5 local companies are addressing the pandemic head-on – DC Inno Coronavirus made 2020 the year of the pivot. But the D.C.-area ventures having real, direct impact on the Covid-19 crisis…Super UserAugust 31, 2020
News Catalent to make drug substance for AstraZeneca’s COVID-19 vaccine candidate – Reuters (Reuters) - Catalent Inc said on Monday its Maryland facility would make the drug substance used in the COVID-19 vaccine…Super UserAugust 31, 2020
News Alexandria Real Estate Equities pays $590.4 million for huge portion of Parmer RTP – Triangle Business Journal A huge portion of a campus in Research Triangle Park has been sold in a deal that tops $590 million.…Super UserAugust 31, 2020
News J.P. Morgan on the state of life sciences and strategies to fuel innovation – MedCity News In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says…Super UserAugust 31, 2020
News Qiagen to launch digital, portable test for COVID-19 antibodies, preordering 900K for U.S. | FierceBiotech Qiagen has announced plans to launch a new digital test for COVID-19 antibodies that can run multiple samples at once…Super UserAugust 31, 2020
News OS Therapies to develop BlinkBio next-generation Antibody Drug Conjugate (ADC) technology; BlinkBio CEO Colin Goddard joins OS Therapies Board | BioSpace CAMBRIDGE, Md. and LONDON, Aug. 26, 2020 (GLOBE NEWSWIRE) -- OS Therapies, and late-stage clinical research biotechnology company focused on…Super UserAugust 31, 2020
News Emergent BioSolutions Announces Appointment of Marvin White to the Company’s Board of Directors NYSE:EBS GAITHERSBURG, Md., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors…Super UserAugust 31, 2020
News Genomic Analysis Suggests Some Endangered Species May Be at High Risk of SARS-CoV-2 Humans are not the only species facing a potential threat from SARS-CoV-2, according to the results of a study by…Super UserAugust 31, 2020